# Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

> **NCT07147309** · — · NOT_YET_RECRUITING · sponsor: **Weibing Miao, PhD** · enrollment: 60 (estimated)

## Conditions studied

- Epilepsy
- PET / MR
- Synaptic Vesicle Proteins
- Microglial Activation
- FDG PET

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07147309
- **Lead sponsor:** Weibing Miao, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07147309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07147309, "Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07147309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*